Nakayama Toshihiro, Akabane Miho, Imaoka Yuki, Esquivel Carlos O, Melcher Marc L, Sasaki Kazunari
Division of Abdominal Transplant, Department of Surgery, Stanford University Medical Center, Stanford, CA.
Transplant Direct. 2024 Oct 18;10(11):e1722. doi: 10.1097/TXD.0000000000001722. eCollection 2024 Nov.
Liver transplantation (LT) outcomes are influenced by donor-recipient size mismatch. This study re-evaluated the impact on graft size discrepancies on survival outcomes.
Data from 53 389 adult LT recipients from the United Network for Organ Sharing database (2013-2022) were reviewed. The study population was divided by the body surface area index (BSAi), defined as the ratio of donor body surface area (BSA) to recipient BSA, into small-for-size (BSAi < 0.78), normal-for-size (BSAi 0.78-1.24), and large-for-size (BSAi > 1.24) grafts in deceased donor LT (SFSD, NFSD, and LFSD). Multivariate Cox regression and Kaplan-Meier survival analyses were conducted.
The frequency of size mismatch in deceased donor LT increased over the past 10 y. SFSD had significantly worse 90-d graft survival ( < 0.01), and LFSD had inferior 1-y graft survival among 90-d survivors ( = 0.01). SFSD was hazardous within 90 d post-LT because of vascular complications. Beyond 1 y, graft size did not affect graft survival. LFSD risk within the first year was mitigated with lower model for end-stage liver disease (MELD) 3.0 scores (<35) or shorter cold ischemia time (<8 h).
The negative impacts on donor-recipient size mismatch on survival outcomes are confined to the first year post-LT. SFSD is associated with a slight decrease in 90-d survival rates. LFSD should be utilized more frequently by minimizing cold ischemia time to <8 h, particularly in patients with MELD 3.0 scores below 35. These findings could improve donor-recipient matching and enhance LT outcomes.
肝移植(LT)的结果受供体-受体大小不匹配的影响。本研究重新评估了移植物大小差异对生存结果的影响。
回顾了器官共享联合网络数据库(2013 - 2022年)中53389例成年LT受者的数据。研究人群根据体表面积指数(BSAi)进行划分,BSAi定义为供体体表面积(BSA)与受体BSA之比,在已故供体LT中分为小体积移植物(BSAi < 0.78)、正常体积移植物(BSAi 0.78 - 1.24)和大体积移植物(BSAi > 1.24)(SFSD、NFSD和LFSD)。进行了多变量Cox回归和Kaplan - Meier生存分析。
在过去10年中,已故供体LT中大小不匹配的频率有所增加。SFSD的90天移植物存活率显著更差(<0.01),LFSD在90天存活者中的1年移植物存活率较低(=0.01)。由于血管并发症,SFSD在LT后90天内具有危险性。1年后,移植物大小不影响移植物存活。当终末期肝病模型(MELD)评分较低(<35)或冷缺血时间较短(<8小时)时,第一年LFSD的风险会降低。
供体-受体大小不匹配对生存结果的负面影响仅限于LT后的第一年。SFSD与90天存活率略有下降相关。应通过将冷缺血时间缩短至<8小时更频繁地使用LFSD,特别是对于MELD 3.0评分低于35的患者。这些发现可改善供体-受体匹配并提高LT结果。